TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from ImmuPharma ( (GB:IMM) ).
ImmuPharma PLC announced that its top executives will attend the Bio-Europe Conference in Vienna from November 3-5, 2025. This event, known as the premier biopharma partnering forum in Europe, will host over 5,700 life science professionals, fostering innovation and collaboration in the biotech sector, which could enhance ImmuPharma’s industry positioning and stakeholder engagement.
More about ImmuPharma
ImmuPharma PLC is a specialty biopharmaceutical company focused on discovering and developing peptide-based therapeutics. Its portfolio includes novel peptide therapeutics aimed at treating autoimmune diseases and anti-infectives.
Average Trading Volume: 11,732,053
Technical Sentiment Signal: Buy
Current Market Cap: £58.32M
Learn more about IMM stock on TipRanks’ Stock Analysis page.